OABI FY 2024 Earnings — OmniAb, Inc. Revenue & Financial Results | Market Cap Arena

OABIOmniAb, Inc.

$231M

FY 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$26M-22.8% YoY

Gross Profit

$26M100.0% margin

Operating Income

-$75M-282.3% margin

Net Income

-$62M-235.1% margin

EPS (Diluted)

$-0.61

Cash Flow

Operating Cash Flow

-$40M

Free Cash Flow

-$42M

Stock-Based Comp.

$21M

Balance Sheet

Total Assets

$326M

Total Liabilities

$38M

Stockholders' Equity

$288M

Cash & Equivalents

$28M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$26M	$34M	-22.8%
Gross Profit	$26M	$34M	-22.8%
Operating Income	-$75M	-$69M	-7.3%
Net Income	-$62M	-$51M	-22.5%